{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T21:48:32Z","timestamp":1761428912128,"version":"3.38.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jcp.0b013e3181fa05bb","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T09:06:35Z","timestamp":1288343195000},"page":"683-687","source":"Crossref","is-referenced-by-count":9,"title":["Association of 9-Hydroxy Risperidone Concentrations With Risk of Switching or Discontinuation in the Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease Trial"],"prefix":"10.1097","volume":"30","author":[{"given":"Alette M.","family":"Wessels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert G.","family":"Anyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Marder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Bies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"12","key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.","volume":"288","author":"Lyketsos","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer's disease.","volume":"46","author":"Mega","year":"1996","journal-title":"Neurology"},{"issue":"5","key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.","volume":"293","author":"Sink","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/PL00005334","article-title":"Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4.","volume":"359","author":"Fang","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02245444","article-title":"Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.","volume":"114","author":"van Beijsterveldt","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s002130000576","article-title":"Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia.","volume":"153","author":"Spina","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"suppl 11","key":"R8-7-20210128","first-page":"12","article-title":"Pharmacokinetics and drug interactions: update for new antipsychotics.","volume":"57","author":"Ereshefsky","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007691-199808000-00004","article-title":"Serum concentrations and side effects in psychiatric patients during risperidone therapy.","volume":"20","author":"Olesen","year":"1998","journal-title":"Ther Drug Monit"},{"issue":"4","key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/ajp.155.4.499","article-title":"Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.","volume":"155","author":"Bondolfi","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"4","key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bcp.1999.47.4.460","article-title":"Serum concentrations and clinical effects of risperidone in schizophrenic patients in Singapore-a preliminary report.","volume":"47","author":"Lee","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.","volume":"60","author":"Katz","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.","volume":"64","author":"Brodaty","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/gps.1409","article-title":"Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.","volume":"20","author":"Brodaty","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"issue":"15","key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00019442-200111000-00004","article-title":"National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.","volume":"9","author":"Schneider","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.schbul.a006989","article-title":"Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.","volume":"29","author":"Swartz","year":"2003","journal-title":"Schizophr Bull"},{"issue":"5","key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jps.2600820503","article-title":"Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients.","volume":"82","author":"Aravagiri","year":"1993","journal-title":"J Pharm Sci"},{"issue":"12","key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0090-9556(25)08211-X","article-title":"Absorption, metabolism, and excretion of risperidone in humans.","volume":"21","author":"Mannens","year":"1993","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02246543","article-title":"Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.","volume":"122","author":"Snoeck","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"15","key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-440X(75)90019-X","article-title":"The many faces of akathisia.","volume":"16","author":"Van Putten","year":"1975","journal-title":"Compr Psychiatry"},{"issue":"3","key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/YCO.0b013e32832a16da","article-title":"Akathisia and second-generation antipsychotic drugs.","volume":"22","author":"Kumar","year":"2009","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201012000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T11:18:07Z","timestamp":1740655087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201012000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181fa05bb","relation":{},"ISSN":["0271-0749"],"issn-type":[{"type":"print","value":"0271-0749"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}